Latest Tax Incentives News

AuMEGA Metals has announced a C$5.35 million capital raising via a flow-through unit offer aimed at advancing its exploration projects in Newfoundland and Labrador. The offer includes shares and warrants, targeting Canadian charity investors with tax incentives.

Chimeric Therapeutics has secured a $1.785 million advance against its anticipated FY26 Research and Development Tax Incentive to bolster its clinical trial pipeline and working capital.

Galan Lithium’s Hombre Muerto West project in Argentina is 92% through Phase 1 construction, with commissioning and first lithium chloride concentrate production expected in 2026.

Elixir Energy has reached a key milestone by drilling and casing the heel of its Lorelle-3H well in Queensland’s Taroom Trough, setting the stage for horizontal drilling aimed at unlocking commercial gas flow.

FBR Limited reports a significant reduction in half-year losses alongside new robotic product launches, yet cash flow challenges raise questions about its financial sustainability.

Norwood Systems Limited reported a significant revenue increase for the half-year ended December 2025, alongside a widening net loss and strategic progress with Tier-1 telecom customers. The company secured additional funding and advanced its AI-driven voice platforms in collaboration with global hyperscalers.

InFocus Group Holdings Limited reported a 37% revenue increase to AUD 2.74 million for H1 FY26, alongside a substantial net loss of nearly AUD 3 million, as it invests in new digital asset and iGaming ventures.

Pointerra Limited reported a $2.14 million loss for the half-year ending December 2025 amid a 51% revenue decline, yet the company highlights promising contract wins and a growing recurring revenue base that could drive a turnaround in the second half.

Environmental Clean Technologies Limited reported a $2.58 million loss for the half-year ended December 2025, marking a strategic pivot with the acquisition of Terrajoule Pty Ltd and exclusive rights to innovative remediation technology.

Sparc Technologies Limited reported a significant net loss of $1.86 million for the half-year ended December 2025, highlighting ongoing financial pressures despite continued R&D efforts. The company flagged material uncertainty over its ability to continue as a going concern.

Entropy Neurodynamics reports a 14.8% reduction in half-year losses while progressing a pioneering clinical trial for Binge Eating Disorder using its proprietary psychedelic drug TRP-8803. The company also secured $6.1 million in new funding and strategic collaborations to enhance its neuropsychiatry platform.

Harvest Technology Group’s half-year report reveals a 50% revenue decline and a widening net loss, offset by a $6 million funding facility and strategic partnerships.